G01N 2333/60
Growth-hormone releasing factors
Official title: Growth-hormone releasing factors (GH-RF) (Somatoliberin)
G01N2333/60 (Growth-hormone releasing factors) appears on 14 US grants and 4 published applications in this corpus.
Search patents in G01N- Granted patents
- 14
- Published applications
- 4
- Assignees
- 7
- Inventors
- 26
- Latest grant
- 7 Dec 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Endothelial cell derived exosomes and uses thereof7 Dec 2021US 11,193,943 B2
- Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness7 Aug 2018US 10,039,813 B2Massachusetts Institute of Technology
- Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness21 Nov 2017US 9,821,042 B2Massachusetts Institute of Technology
- Biomarkers13 Aug 2013US 8,507,209 B2Otago Innovation Limited
- Detection of molecules in samples20 Jan 2004US 6,680,207 B1Generic Biologicals Limited
- Endothelial Cell Derived Exosomes and Uses Thereof9 Aug 2018US 2018/0224465 A1
- Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness3 Mar 2016US 2016/0058851 A1Massachusetts Institute of Technology
- Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness22 Oct 2015US 2015/0297691 A1Massachusetts Institute of Technology
- Biomarkers13 Jan 2011US 2011/0008808 A1Otago Innovation Limited
Most cited
By later US patents
- Nucleic acid molecule encoding the porcine growth hormone receptor22US 5,583,010 AAmerican Cyanamid Company · 1996
- Nucleic acid encoding the growth hormone releasing hormone receptor17US 5,591,641 AAmerican Cyanamid Company · 1997
- Biomarkers11US 8,507,209 B2Otago Innovation Limited · 2013
- Molecular cloning of the ovine pituitary growth hormone releasing hormone receptor8US 5,852,187 AUniversity of Virginia Patent Foundation · 1998
- Nucleic acid encoding the growth hormone releasing hormone receptor3US 5,612,470 AAmerican Cyanamid Company · 1997